农场内补充反保护的尼亚:一项随机临床试验
K C Krogstad1, R J Vlietstra2, J R Pursley3
1Department of Animal Science, Michigan State University, East Lansing, MI 48824; Department of Animal Science, The Ohio State University, Wooster, OH 44691.
Journal of dairy science
|December 18, 2024
概括
在早期哺乳期,补充乳牛以反保护氨酸 (RPN) 增加了第一和第二平价奶牛的奶产. 然而,RPN并没有显著影响乳腺炎,生育率或群体保留率.
科学领域:
- 动物的营养和新陈代谢
- 乳牛的健康和生产力
- 维生素B3补充剂的使用
背景情况:
- 体微生物合成B族维生素,但补充剂可能会改善动物的健康.
- 在过渡期内补充流血保护氨酸 (RPN) 可能会减少脂解,改善乳牛的产后健康和生育能力.
研究的目的:
- 评估RPN补充剂在牛奶中的前21天 (DIM) 对奶牛健康和生产力的影响.
- 假设RPN可以减少乳腺炎,提高生育能力,降低离开群体的风险.
主要方法:
- 荷尔斯坦牛 (n=1074) 被分配给接受RPN (n=481) 或控制 (CON,n=593) 在前21 DIM.
- 收集了牛奶产量,成分,身体状况得分 (BCS),健康和生殖记录.
- 血尼亚,代谢和炎症生物标志物在一组母牛中进行了评估.
主要成果:
- 补充RPN增加了血尼古丁胺和降低了血胰岛素度.
- 循环BHB和自由脂肪酸度在补充RPN的奶牛中更高,特别是在更高的平价中.
- 在整个哺乳期内,RPN增加了第一和第二平价奶牛的乳产,分别为658公斤和675公斤.
结论:
- 在早期哺乳期服用RPN补充剂可以提高年轻奶牛的奶产,但不会影响乳腺炎发病率,怀孕率或杀率.
- 需要进一步的研究来优化RPN补充策略,以了解乳牛的时间和代谢影响.
相关概念视频
2° Amines to N-Nitrosamines: Reaction with NaNO2
Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Bioavailability Study Design: Absolute Versus Relative Bioavailability
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...


